Tower Research Capital (TRC)’s Kite Pharma, Inc. KITE Stock Holding History

Tower Research Capital (TRC)’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,039	Closed	-$726K	–	4456
2017 Q3	$726K	Buy	+4,039	New	+$563K	0.06%	181
2017 Q1	–	Sell	-4,938	Closed	-$222K	–	4494
2016 Q4	$222K	Buy	+4,938	New	+$242K	0.02%	594
2016 Q1	–	Sell	-950	Closed	-$59K	–	5490
2015 Q4	$59K	Sell	950 -592	-38%	-$41.7K	0.01%	485
2015 Q3	$85K	Buy	1,542 +321	+26%	+$20.2K	0.01%	658
2015 Q2	$74K	Buy	1,221 +620	+103%	+$35.4K	0.01%	1080
2015 Q1	$35K	Buy	+601	New	+$40.3K	﹤0.01%	1779
2014 Q4	–	Sell	-249	Closed	-$7K	–	5146
2014 Q3	$7K	Buy	+249	New	+$6.16K	﹤0.01%	3109

Tower Research Capital (TRC)'s KITE Position: Q4 2017 in Review

Tower Research Capital (TRC) sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 4,039 shares — an estimated $726K sold.

Tower Research Capital (TRC) first reported a position in KITE in Q3 2014 and held it in 7 quarters. The position peaked at $726K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Tower Research Capital (TRC) reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Tower Research Capital (TRC) sold 4,039 Kite Pharma, Inc. shares in Q4 2017, an estimated $726K.
Tower Research Capital (TRC) first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 7 quarters.
Tower Research Capital (TRC)'s Kite Pharma, Inc. position peaked at $726K in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.